Featured Resources
-
Consumer Involvement and Engagement Toolkit
The Consumer Involvement and Engagement Toolkit provides practical advice for researchers and research organisations wishing to conduct patient-centred clinical trials.
-
COVID-19
We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.
-
What is an adaptive clinical trial?
This video, created by Adaptive Health Intelligence, explains what adaptive clinical trials are and how they differ from traditional clinical trial designs.
Search Resources
General search and filters
Filter by:
Topics
Type of Resource
Results filtered by:
-
ACTA Whistleblower Policy
-
HeSANDA Stakeholder Consultation Project
-
Protocols and Statistical Analysis Plans (SAPs) for Adaptive Trials
-
Clinical Trials 2021: National Tribute and Award Ceremony Video Recording
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
ARDC HeSANDA Initiative Background Paper
-
ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
-
Risk Management: Guidance for Clinical Trial Networks
-
Consumer involvement in clinical trials: ethics committee members and research governance personnel training webinar – an overview
-
ACTA Comparative Effectiveness Trials: Requirements for Low Risk Ethics Review
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 2
-
Establishing a CTN: A Facilitated Workshop for Clinicians and Researchers ACTA Summit 2020